Biomet BMET

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Zimmer Sees Anemic Domestic Demand Offset by Stronger International Markets in 2Q

      Commentary

      Thu, 24 Jul 2014

      its acquisition of midtier competitor Biomet . Antitrust regulators in Europe and the ..... will close, and we continue to include Biomet in our valuation. With quarterly revenue ..... its spine business with the addition of Biomet . There just is not enough high-quality

    2. KKR Reports Solid 2Q; KFN Acquisition Closes, Boosting Recurring Income Stream

      Commentary

      Thu, 24 Jul 2014

      Blackstone's 8.4%, Carlyle's 5%, and the S&P 500's 4.7% increases. Upcoming sales transactions for US Foods and Biomet will generate more incentive income in the next quarter or two. With the completion of the KFN deal, KKR (at the asset manager

    3. “Tax Reform is Impossible – Until it is Inevitable”

      Headlines

      Tue, 22 Jul 2014

      Biomet moves closer to private territory.

    4. Tides Turn for These Orthopedic Firms

      Headlines

      Mon, 30 Jun 2014

      announcement that Zimmer ZMH plans to acquire Biomet , the competitive dynamics in the orthopedic ..... orthopedic surgeons. Zimmer's acquisition of Biomet removes one midtier competitor from the ..... Economic Moat Rating, and the addition of Biomet (which we had also rated as wide moat

    5. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

      Headlines

      Thu, 26 Jun 2014

      Zimmer 's ZMH "> ZMH credit rating, which we cut to BBB+ from AA on its plan to purchase Biomet for $13.35 billion, including the assumption of Biomet 's $5.5 billion in net debt. Excluding synergies, Zimmer's debt/EBITDA will rise

    6. Orthopedic Competitors Are Circling Smith & Nephew

      Commentary

      Thu, 5 Jun 2014

      After the announcement of Zimmer's plan to acquire midtier rival Biomet , all eyes are on Smith & Nephew as the next target. With hints of Medtronic and Stryker investigating the possibility of purchasing

    7. New Morningstar Analyst Report for Zimmer Holdings Inc

      Stock Reports

      Mon, 12 May 2014

      pending acquisition and integration of Biomet . Unlike the Centerpulse acquisition ..... much product or geographic overlap, the Biomet deal could be more sticky, especially ..... share, which reflects the addition of Biomet 's business. We estimate the combined

    8. Smith & Nephew Delivers Anemic First-Quarter Results

      Commentary

      Wed, 7 May 2014

      Against the backdrop of rival Zimmer's planned acquisition of Biomet , we think S&N faces a more difficult task of remaining competitive ..... implant makers will control close to 80% of the market after the Biomet deal closes, and expect most hospitals will want to contract

    9. Smith & Nephew Delivers Anemic First-Quarter Results; No Change to Fair Value Estimate

      Commentary

      Thu, 1 May 2014

      Against the backdrop of rival Zimmer's planned acquisition of Biomet , we think S&N faces a more difficult task of remaining competitive ..... implant makers will control close to 80% of the market after the Biomet deal closes, and expect most hospitals will want to contract

    10. Stryker Delivers Strong Fourth Quarter; Plan Modest Increase to Fair Value Estimate

      Commentary

      Thu, 23 Jan 2014

      economic moat. We were heartened to see stronger growth in the large joint replacement market as the year closed. Along with Biomet and Johnson & Johnson, Stryker also posted healthy year-over-year sales gains in hips and knees. Although the fourth quarter

    « Prev12345Next »
    Content Partners